Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 6 studies | 32% ± 11% | |
| interneuron | 6 studies | 23% ± 6% | |
| cardiac muscle cell | 6 studies | 50% ± 19% | |
| GABAergic neuron | 5 studies | 32% ± 11% | |
| granule cell | 4 studies | 61% ± 23% | |
| endothelial cell | 3 studies | 26% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 88% | 2919.22 | 2322 / 2642 | 75% | 13.11 | 532 / 705 |
| heart | 95% | 3196.51 | 814 / 861 | 0% | 0 | 0 / 0 |
| ovary | 51% | 247.67 | 91 / 180 | 1% | 0.06 | 5 / 430 |
| blood vessel | 17% | 61.71 | 224 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 15% | 55.01 | 37 / 241 | 0% | 0 | 0 / 0 |
| breast | 8% | 25.39 | 35 / 459 | 5% | 0.31 | 61 / 1118 |
| adrenal gland | 1% | 7.77 | 3 / 258 | 9% | 0.98 | 20 / 230 |
| thymus | 0% | 1.60 | 3 / 653 | 8% | 0.57 | 49 / 605 |
| lung | 2% | 5.21 | 11 / 578 | 2% | 0.06 | 20 / 1155 |
| skin | 0% | 1.05 | 9 / 1809 | 3% | 0.13 | 13 / 472 |
| esophagus | 2% | 3.10 | 22 / 1445 | 1% | 0.01 | 1 / 183 |
| uterus | 0% | 0 | 0 / 170 | 2% | 0.04 | 8 / 459 |
| eye | 0% | 0 | 0 / 0 | 1% | 0.03 | 1 / 80 |
| prostate | 1% | 2.62 | 2 / 245 | 0% | 0.00 | 2 / 502 |
| pancreas | 0% | 0 | 0 / 328 | 1% | 0.02 | 2 / 178 |
| kidney | 0% | 0 | 0 / 89 | 1% | 0.20 | 9 / 901 |
| stomach | 1% | 1.02 | 2 / 359 | 0% | 0.01 | 1 / 286 |
| intestine | 0% | 0.59 | 3 / 966 | 0% | 0.00 | 1 / 527 |
| bladder | 0% | 0 | 0 / 21 | 0% | 0.21 | 2 / 504 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| adipose | 0% | 0 | 0 / 1204 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| liver | 0% | 0 | 0 / 226 | 0% | 0 | 0 / 406 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005739 | Cellular component | mitochondrion |
| GO_0051018 | Molecular function | protein kinase A binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | SPHKAP |
| Protein name | A-kinase anchor protein SPHKAP (SPHK1-interactor and AKAP domain-containing protein) (Sphingosine kinase type 1-interacting protein) |
| Synonyms | SKIP KIAA1678 |
| Description | FUNCTION: Anchoring protein that binds preferentially to the type I regulatory subunit of c-AMP-dependent protein kinase (PKA type I) and targets it to distinct subcellular compartments. May act as a converging factor linking cAMP and sphingosine signaling pathways. Plays a regulatory role in the modulation of SPHK1. . |
| Accessions | Q2M3C7 ENST00000392056.8 [Q2M3C7-1] ENST00000344657.5 [Q2M3C7-2] |
